mhurhangee/ep-ind-claims huggingface dataset:
A tissue-removing catheter for removing tissue in a body lumen, the tissue-removing catheter comprising: an elongate body having an axis and proximal and distal end portions (16, 18) spaced apart from one another along the axis, the elongate body being sized and shaped to be received in the body lumen; a tissue-removing element mounted on the distal end portion of the elongate body, the tissue-removing element being configured to remove tissue as the tissue-removing element is rotated by the elongate body within the body lumen; and an inner liner received within the elongate body and defining a guidewire lumen, the inner liner isolating an interior of the guidewire lumen from the elongate body and tissue-removing element such that torsional force is not transferred from the elongate body and tissue-removing element to the interior of the guidewire lumen when the elongate body and tissue-removing element are rotated during operation of the tissue-removing catheter, the inner liner including a distal end margin configured to extend distally of the tissue-removing element, the distal end margin having a construction different from a construction of a second portion of the inner liner which is positioned proximal of the distal end margin, and wherein the distal end margin of the inner liner is more flexible than the remaining portion of the inner liner. an elongate body having an axis and proximal and distal end portions (16, 18) spaced apart from one another along the axis, the elongate body being sized and shaped to be received in the body lumen; a tissue-removing element mounted on the distal end portion of the elongate body, the tissue-removing element being configured to remove tissue as the tissue-removing element is rotated by the elongate body within the body lumen; and an inner liner received within the elongate body and defining a guidewire lumen, the inner liner isolating an interior of the guidewire lumen from the elongate body and tissue-removing element such that torsional force is not transferred from the elongate body and tissue-removing element to the interior of the guidewire lumen when the elongate body and tissue-removing element are rotated during operation of the tissue-removing catheter, the inner liner including a distal end margin configured to extend distally of the tissue-removing element, the distal end margin having a construction different from a construction of a second portion of the inner liner which is positioned proximal of the distal end margin, and wherein the distal end margin of the inner liner is more flexible than the remaining portion of the inner liner.
A protocol data unit, PDU, session activation method, characterized by comprising: receiving, by a session management function, SMF, entity, a downlink data notification message; determining, by the SMF entity, that a PDU session for transmitting the downlink data is a multi-access PDU session, and then determining at least one access and mobility management function, AMF, entity corresponding to the multi-access PDU session; and sending, by the SMF entity, a message configured to activate the PDU session to the at least one AMF entity, wherein the message configured to activate the PDU session carries at least a PDU session identifier of the multi-access PDU session, and the message configured to activate the PDU session is used for enabling the at least one AMF entity to activate any one or specific one of at least two user plane connections of the multi-access PDU session corresponding to the PDU session identifier. receiving, by a session management function, SMF, entity, a downlink data notification message; determining, by the SMF entity, that a PDU session for transmitting the downlink data is a multi-access PDU session, and then determining at least one access and mobility management function, AMF, entity corresponding to the multi-access PDU session; and sending, by the SMF entity, a message configured to activate the PDU session to the at least one AMF entity, wherein the message configured to activate the PDU session carries at least a PDU session identifier of the multi-access PDU session, and the message configured to activate the PDU session is used for enabling the at least one AMF entity to activate any one or specific one of at least two user plane connections of the multi-access PDU session corresponding to the PDU session identifier.
A method of determining a respiration rate from a signal representative of a recorded respiration episode, the method comprising providing a starter pointer and an end pointer to point to a start position and an end position of the signal representative of the episode, and characterised by updating the start and end pointers to identify the start and end positions of two or more uncorrupted segments within said signal, the uncorrupted segments being separated by corrupted segments, identifying the longest of the uncorrupted segments or the segment with a lowest average absolute deviation, AAD, between respiration peaks or troughs, and determining a respiration rate from the longest uncorrupted segment or the segment with the lowest AAD.
A method for producing a component consisting of at least two plastics parts (2, 3), wherein the plastics parts are produced by means of an injection moulding process in an injection mould which comprises a tool with at least two oppositely-positionable tool parts (4a,4b) being positionable relative to each other, wherein to produce the plastics parts by means of the injection moulding process the tool is closed by bringing the tool parts together in a tool direction and plastics material is injected into at least two spaced-apart cavities delimited by the tool parts, after which the tool is opened and the tool parts (4a,4b), on each of which one of the plastics parts (2,3) is supported, are so positioned that the tool parts and the plastics parts are arranged in a welding position, and the plastics parts in the injection mould are then connected to each other by welding in that in the welding position a heating element is introduced into the intermediate space between the plastics parts, wherein regions which are to be welded to each other, namely edge regions of the plastics parts are heated by the heating element in a contactless manner, after which the heating element is removed from the intermediate space and then the tool parts (4a,4b) are moved towards each other from the welding position in a welding direction inclined to the tool direction such that the regions of the plastics parts which are to be welded to each other are brought into contact with each other and are welded to each other at their heated regions to form the component, characterised in that a hot gas heating element is used as the heating element.
A network device, configured to: allocate network resources in a communication network according to a current state, wherein the current state is represented by a state variable vector, wherein the state variable vector comprises at least one of: a plurality of key performance indicator, KPI, values representing a service level agreement, SLA, in a plurality of services; number of service requests for each service in the plurality of services; and number of resources allocated to each service in the plurality of services; determine a plurality of permissible actions from the current state, wherein each action in the plurality of permissible actions comprises a change to the current state; simulate a plurality of state paths for each action in the plurality of permissible actions, wherein each state path in the plurality of state paths comprises a plurality of consecutive actions, each of the consecutive actions causing a state change; calculate a cost value for each action in the plurality of permissible actions based on the corresponding plurality of state paths; choose an action from the plurality of permissible actions based on the cost value of each action in the plurality of permissible actions; transition to a new state by performing the chosen action; and allocate the network resources in the communication network according to the new state. a plurality of key performance indicator, KPI, values representing a service level agreement, SLA, in a plurality of services; number of service requests for each service in the plurality of services; and number of resources allocated to each service in the plurality of services; determine a plurality of permissible actions from the current state, wherein each action in the plurality of permissible actions comprises a change to the current state; simulate a plurality of state paths for each action in the plurality of permissible actions, wherein each state path in the plurality of state paths comprises a plurality of consecutive actions, each of the consecutive actions causing a state change; calculate a cost value for each action in the plurality of permissible actions based on the corresponding plurality of state paths; choose an action from the plurality of permissible actions based on the cost value of each action in the plurality of permissible actions; transition to a new state by performing the chosen action; and allocate the network resources in the communication network according to the new state.
A catalyst system comprising i) a 2-[(phosphinyl)aminyl] cyclic imine transition metal compound complex and ii) an organoaluminum compound, wherein the 2-[(phosphinyl)aminyl] cyclic imine transition metal compound complex has the structure: wherein: R 1 and R 2 are each independently a C 1 to C 20 organyl group consisting essentially of inert functional groups, R 3 is hydrogen or a C 1 to C 20 organyl group, L is -(CR'R") m - where each R' and R" independently is a hydrogen or a C 1 to C 10 organyl group consisting essentially of inert functional groups and m is 1, 2, or 3, R 11 is hydrogen or a C 1 to C 20 organyl group consisting essentially of inert functional groups, R 12, R 13, R 14, R 21, R 22, R 23, and R 24 are each independently hydrogen or a C 1 to C 20 organyl group consisting essentially of inert functional groups, optionally R 11 and R 13 or R 14 are joined to form a ring or ring system, and MX p represents a transition metal compound where M is chromium, X is a monoanion, and p ranges from 2 to 6. R 1 and R 2 are each independently a C 1 to C 20 organyl group consisting essentially of inert functional groups, R 3 is hydrogen or a C 1 to C 20 organyl group, L is -(CR'R") m - where each R' and R" independently is a hydrogen or a C 1 to C 10 organyl group consisting essentially of inert functional groups and m is 1, 2, or 3, R 11 is hydrogen or a C 1 to C 20 organyl group consisting essentially of inert functional groups, R 12, R 13, R 14, R 21, R 22, R 23, and R 24 are each independently hydrogen or a C 1 to C 20 organyl group consisting essentially of inert functional groups, optionally R 11 and R 13 or R 14 are joined to form a ring or ring system, and MX p represents a transition metal compound where M is chromium, X is a monoanion, and p ranges from 2 to 6.
A mower (10, 16) for connection to an agricultural tractor, the mower (10,16) comprises a cutting apparatus for severing a standing crop from the ground and a crop guide apparatus for directing an airborne flow of crop material rearwardly therefrom to form a windrow on the ground, the crop guide apparatus comprising: - first and second windrow guide shields (25a,25b; 125), each windrow guide shield (25a,25b; 125) having generally opposing forward and rearward ends and positioned on opposing lateral sides of the airborne flow of crop material, each of the windrow guide shields (25a,25b; 125) being pivotally coupled near the forward end of the mower (10, 16) to enable the respective rearward ends of the shields to move laterally inwardly and outwardly relative to the airborne crop flow; - an actuator configured to cause the first and second windrow guide shields to pivot between opposing right and left extreme positions; and - a control system configured for receiving at least one input signal (184, 187, 189) from the mower or an operator input device, the at least one input signal is used to determine a desired guide shield position based upon the received at least one input signal and initiating an actuator signal representative thereof, the actuator signal being communicated to the actuator to cause the pivotal position of the first and second windrow guide shields to laterally influence the windrow as the tractor moves away from a straight-ahead course characterised in that the control system is further configured for receiving an at least one input signal from a steering angle sensor for measuring a steering angle (Φ) of the agricultural tractor. - first and second windrow guide shields (25a,25b; 125), each windrow guide shield (25a,25b; 125) having generally opposing forward and rearward ends and positioned on opposing lateral sides of the airborne flow of crop material, each of the windrow guide shields (25a,25b; 125) being pivotally coupled near the forward end of the mower (10, 16) to enable the respective rearward ends of the shields to move laterally inwardly and outwardly relative to the airborne crop flow; - an actuator configured to cause the first and second windrow guide shields to pivot between opposing right and left extreme positions; and - a control system configured for receiving at least one input signal (184, 187, 189) from the mower or an operator input device, the at least one input signal is used to determine a desired guide shield position based upon the received at least one input signal and initiating an actuator signal representative thereof, the actuator signal being communicated to the actuator to cause the pivotal position of the first and second windrow guide shields to laterally influence the windrow as the tractor moves away from a straight-ahead course characterised in that the control system is further configured for receiving an at least one input signal from a steering angle sensor for measuring a steering angle (Φ) of the agricultural tractor.
A spacer comprising: a first elongate strip formed of a metal and having a first surface; a second elongate strip, characterized in that the second elongate strip is formed of the metal, having a second surface opposing the first surface and including at least one aperture extending through the second elongate strip, wherein the second surface is spaced from the first surface by a distance, and wherein the first and second elongate strips each define a thickness in a range from 0.000254 cm (0.0001 inches) to 0.0254 cm (0.01 inches); and at least one filler arranged between the first and second surfaces, the filler providing increased structural strength by supporting the first and second elongate strips, and the filler including a desiccant, wherein the first and second elongate strips have an undulating shape capable of expanding by stretching to form a corner of said spacer, such that a part of the spacer is oriented at an angle from another part of the spacer. a first elongate strip formed of a metal and having a first surface; a second elongate strip, characterized in that the second elongate strip is formed of the metal, having a second surface opposing the first surface and including at least one aperture extending through the second elongate strip, wherein the second surface is spaced from the first surface by a distance, and wherein the first and second elongate strips each define a thickness in a range from 0.000254 cm (0.0001 inches) to 0.0254 cm (0.01 inches); and at least one filler arranged between the first and second surfaces, the filler providing increased structural strength by supporting the first and second elongate strips, and the filler including a desiccant, wherein the first and second elongate strips have an undulating shape capable of expanding by stretching to form a corner of said spacer, such that a part of the spacer is oriented at an angle from another part of the spacer.
An enzyme substrate comprising: a) a fluorogenic dye moiety of structural formula: wherein Y is alkyl or substituted alkyl; X is -N -, wherein R is H, alkyl or substituted alkyl; L is a linker; and each R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9, R 10, R 11, R 12 and R 13 is independently H, alkyl or substituted alkyl, wherein an alkyl has from 1 to 10 carbon atoms, and a substituted alkyl is an alkyl having from 1 to 10 carbon atoms in which one or more hydrogen atoms are replaced with one or more of a halogen, Ci-Cs alkyl, sulfate, sulfonate, sulfone, amino, ammonium, amido, nitrile, nitro, phenoxy, or a phenyl moiety; and b) a peptide covalently attached to the fluorogenic dye moiety through the linker L, wherein the peptide comprises or is attached to a caspase cleavage site, and wherein the peptide optionally comprises an N-terminal acyl. a) a fluorogenic dye moiety of structural formula: wherein Y is alkyl or substituted alkyl; X is -N -, wherein R is H, alkyl or substituted alkyl; L is a linker; and each R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9, R 10, R 11, R 12 and R 13 is independently H, alkyl or substituted alkyl, wherein an alkyl has from 1 to 10 carbon atoms, and a substituted alkyl is an alkyl having from 1 to 10 carbon atoms in which one or more hydrogen atoms are replaced with one or more of a halogen, Ci-Cs alkyl, sulfate, sulfonate, sulfone, amino, ammonium, amido, nitrile, nitro, phenoxy, or a phenyl moiety; and Y is alkyl or substituted alkyl; X is -N -, wherein R is H, alkyl or substituted alkyl; L is a linker; and each R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9, R 10, R 11, R 12 and R 13 is independently H, alkyl or substituted alkyl, wherein an alkyl has from 1 to 10 carbon atoms, and a substituted alkyl is an alkyl having from 1 to 10 carbon atoms in which one or more hydrogen atoms are replaced with one or more of a halogen, Ci-Cs alkyl, sulfate, sulfonate, sulfone, amino, ammonium, amido, nitrile, nitro, phenoxy, or a phenyl moiety; and b) a peptide covalently attached to the fluorogenic dye moiety through the linker L,
A packaging for a product comprising: a container including a first body layer and a second body layer connected at a fold, said first and second body layers (24a, 24b) configured to collapse to a first position and expand to a second position, and one or more of said first and second body layers (24a, 24b) defining a void; and a cover including a first side and a second side, said first and second body layers (24a, 24b) being configured to collapse to the first position between the first and second sides (62, 64) of the cover; wherein the cover includes a sidewall and the first and second sides (62, 64) are connected to the sidewall at respective folds; and the container and the cover are constructed as one sheet, characterized in that the cover includes a package opening mechanism positioned on the second side of the cover, wherein the packaging opening mechanism comprises an extension which folds over the second side of the cover at the fold connecting the package opening mechanism to a second sidewall and laying against an exterior surface of the second side of the cover in a surface-to-surface relationship. a container including a first body layer and a second body layer connected at a fold, said first and second body layers (24a, 24b) configured to collapse to a first position and expand to a second position, and one or more of said first and second body layers (24a, 24b) defining a void; and a cover including a first side and a second side, said first and second body layers (24a, 24b) being configured to collapse to the first position between the first and second sides (62, 64) of the cover; wherein the cover includes a sidewall and the first and second sides (62, 64) are connected to the sidewall at respective folds; and the container and the cover are constructed as one sheet, characterized in that the cover includes a package opening mechanism positioned on the second side of the cover, wherein the packaging opening mechanism comprises an extension which folds over the second side of the cover at the fold connecting the package opening mechanism to a second sidewall and laying against an exterior surface of the second side of the cover in a surface-to-surface relationship.
A human antibody, or antigen binding fragment thereof, that binds specifically to human ErbB2, and inhibits Heregulin-induced ErbB2 phosphorylation in MCF7 cells with an EC50 of less than 50ng/ml, wherein the antibody or antigen binding fragment thereof comprises the three heavy chain CDR1, CDR2 and CDR3 amino acid sequences and the three light chain CDR1, CDR2 and CDR3 amino acid sequences, wherein the three heavy chain CDRs and the three light chain CDRs are selected from the group consisting of: (i) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 6, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 8; (ii) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 14, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 16; (iii) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 18, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 20; (iv) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 22, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 24; (v) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 26, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 28; (vi) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 30, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 32; or (vii)the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 34, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 36, wherein the CDRs are as defined by Kabat. (i) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 6, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 8; (ii) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 14, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 16; (iii) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 18, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 20; (iv) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 22, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 24; (v) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 26, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 28; (vi) the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 30, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 32; or (vii)the three CDRs from a heavy chain amino acid sequence of SEQ ID NO: 34, and the three CDRs from a light chain amino acid sequence of SEQ ID NO: 36,